Bristol-Myers Squibb Co (BMY) Stock Could Soon Reward Patient Investors
Bristol-Myers Squibb Co (NYSE: BMY) is 2.92% higher on its value in year-to-date trading and has touched a low of $39.35 and a high of $61.10 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
